We are live on !
Find out more
ATP Life Science Ventures Portfolio holdings
AUM
$898M
Turnover
0%
1-Year Est. Return
84.86%
This Fund
S&P 500
This Quarter Est. Return
-25.46%
1 Year Est. Return
+84.86%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$898M
AUM Growth
-$397M
(-31%)
Cap. Flow
$0
Cap. Flow % of AUM
Cap. Flow %
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.9
years
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Stoke Therapeutics
STOK
$1.71B
| $667M | 74.2% |
17,161,713
| – | – |
2019 Q4
5 quarters
|
|
2
DELISTED
Akero Therapeutics
AKRO
| $169M | 18.83% |
5,830,203
| – | – |
2019 Q4
5 quarters
|
|
|
KDNY
3
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $62.6M | 6.97% |
4,028,937
| – | – |
2020 Q4
1 quarter
|
|
Similar funds
NAM
FBP
PA
ATP Life Science Ventures's Q1 2021 Portfolio in Review
As of Q1 2021, ATP Life Science Ventures held 3 positions worth $898M, down 31% from $1.3B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 0%. ATP Life Science Ventures opened no new positions and made no exits, leaving the 3-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- ATP Life Science Ventures's ten largest holdings make up 100% of its $898M portfolio in Q1 2021.
- ATP Life Science Ventures opened 0 new positions and closed 0 in Q1 2021.
- ATP Life Science Ventures's portfolio value fell 31% quarter-over-quarter to $898M.
Based on ATP Life Science Ventures's 13F filing for Q1 2021, filed 12 May 2021.